Home › Obesity › California › Long Beach
Obesity clinical trials in Long Beach, CA
5 studies for Obesity are looking for participants at sites in and around Long Beach (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RecruitingPhase 3
- Ark Clinical Research, Long Beach
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
- Ark Clinical Research, Long Beach
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
RecruitingPhase 3
- Ark Clinical Research, Long Beach
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
RecruitingPhase 3
- Long Beach Clinical Trials Services Inc, Long Beach
- Ark Clinical Research- Long Beach, Long Beach
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- Cardio Innovation & Resch Ctr, Long Beach
About Obesity
Read about the causes of obesity and find out what you can do to decrease your risk of its associated health issues.
More about Obesity on MedlinePlus
Obesity trials in other cities
- Houston, TX44 studies
- Chicago, IL40 studies
- New York City, NY39 studies
- San Antonio, TX39 studies
- Washington, DC34 studies
- Dallas, TX33 studies
- Orlando, FL33 studies
- Miami, FL28 studies
- Boston, MA26 studies
- Atlanta, GA26 studies
- Los Angeles, CA25 studies
- St. Louis, MO25 studies
Other studies in Long Beach
- Non-Small Cell Lung Cancer11 studies
- Alzheimer's Disease10 studies
- Type 2 Diabetes10 studies
- Breast Cancer8 studies
- Lung Cancer8 studies
- Cancer (all types)6 studies
- Prostate Cancer6 studies
- Dementia5 studies
- Overweight5 studies
- Cardiovascular Disease5 studies
- Migraine5 studies
- Mild Cognitive Impairment4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.